 Bronstein, Gewirtz Grossman, LLC reminds investors that a class action lawsuit has been filed against of LogicBio Therapeutics, Inc. LogicBio or the Company NASDAQ: LOGC and certain of its officers, on behalf of shareholders who purchased or otherwise acquired LogicBio securities between December 3, 2018 and February 10, 2020, inclusive the Class Period. Such investors are encouraged to join this case by visiting the firms site: 